,,iii #aah? ,,congress #b;d ,session ,s4 ,,res4 #gge ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,july #cj1 #bjbd,ms4 ,/ab5[ submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ,,resolution ,express+ support = ! designation ( ,july #ae1 #bjbd1 z 8,national ,leiomyos>coma ,aw>5ess ,day04 ,:]eas leiomyos>coma is a malignant s>coma subtype1 #a ( #gj to #ajj su* subtypes1 t arises 9 smoo? muscle & has sev]al subtypes itself due to its vascul>ity & bone invasion2 ,:]eas leiomyos>coma is designat$ by ! ,national ,in/itutes ( ,heal? z a r>e =m ( canc]2 ,:]eas leiomyos>coma is l>gely resi/ant to /&>d *emo!rapy treatm5ts1 radiation treatm5ts1 & immuno!rapy trials1 ) #dj-ye>-old *emo!rapy treatm5ts /ill 9 use2 ,:]eas leiomyos>coma affects all age gr\ps1 includ+ *ildr51 "y adults1 ! middle-ag$1 & ! eld]ly1 & all g5d]s2 ,:]eas leiomyos>coma is diagnos$ 9 m ?an #b1jjj individuals 9 ! ,unit$ ,/ates ea* ye>2 ,:]eas1 ) respect to leiomyos>coma1 rese>* & cl9ical trials rema9 complicat$ & extremely co/ly due to ! difficulty ( recruit+ pati5ts2 ,:]eas survival & longevity = individuals ) leiomyos>coma has n significantly improv$ = at lea/ #cj ye>s2 ,:]eas multidiscipl9>y c>e coord9ation teams1 because ( _! exp]tise & exp]i5ce1 are critical to ! heal? ( leiomyos>coma pati5ts2 ,:]eas rese>*]s cont9ue to /rive to improve quality ( life = leiomyos>coma pati5ts1 improve outcomes 9 cl9ical trials1 & promote enhanc$ survivor%ip2 & ,:]eas increas$ education & aw>5ess ab\t s>coma & leiomyos>coma w contribute to ! well-be+ ( ! communities ( ! ,unit$ ,/ates3 ,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7 supports ! designation ( ,july #ae1 #bjbd1 z ,national ,leiomyos>coma ,aw>5ess ,day2 7#b7 recognizes ! *all5ges fac$ by leiomyos>coma pati5ts2 & 7#c7 comm5ds ! d$ication ( organizations1 volunte]s1 rese>*]s1 & c>egiv]s across ! ,unit$ ,/ates work+ to improve ! quality ( life ( leiomyos>coma pati5ts & _! families4